Kangai Injection Combined with Platinum-based Chemotherapy for the Treatment of Stage III/IV Non-Small Cell Lung Cancer: A Meta-analysis and Systematic Review of 35 Randomized Controlled Trials
Conclusions: From the available evidence, our results indicate that KAI plus platinum-based chemotherapy could be more effective in improving clinical efficacy, decreasing the incidence of adverse reactions and regulating the tumor immune function than chemotherapy alone in the treatment of stage III/IV NSCLC. Nevertheless, considering the limitations of the included studies, rigorous designed, high-quality, multicenter clinical trials are still need to further confirm the results.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Hongxiao Li, Yuejin Ji, Shiping Zhang, Zishan Gao, Cheng Hu, Rilei Jiang, Meijuan Chen, Guochun Li, Xu Zhang Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | China Health | Clinical Trials | Databases & Libraries | Gastroenterology | Lung Cancer | Non-Small Cell Lung Cancer | Science | Study | Thrombocytopenia